Skip to content

Omeros OMER Balance Sheet Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$1.91M-55.3%$9.66M$2.4M$1.9M$4.26M
$1.05M0.0%$1.05M$1.05M$1.05M$1.05M
$12.03M+70.0%$10.92M$6.91M$6.28M$7.08M
$7.35M-1.6%$7.6M+6.0%$3.76M-38.6%$6.41M+2.1%$7.47M+46.7%
$180.36M+87.5%$215.67M$71.81M$69.65M$96.18M
$1.53M-36.8%$1.77M$2.01M$2.24M$2.42M
$9.52M-31.8%$10.71M$11.81M$12.89M$13.95M
$5.7M+26.7%$5.7M$4.5M$4.5M$4.5M
$133.41M+177%$162.14M$33.69M$26.84M$48.15M
$286.17M+21.7%$325.63M$185.71M$200.57M$235.16M
$5.37M+21.6%$4.76M$12.5M$8.84M$4.41M
$27.81M+12.3%$29.39M$25.75M$26.28M$24.75M
$59.44M-28.6%$78.06M$80.76M$85.5M$83.22M
$0$0$0$0$0
$720K+24.1%$716K$700K$599K$580K
$793.58M+8.8%$791.75M$778.97M$739.95M$729.67M
-$857.64M+9.1%-$913.7M-$1B-$969.23M-$943.81M
-$63.33M+70.3%-$121.23M+33.6%-$220.48M-43.0%-$228.69M-83.5%-$213.55M-199%
$286.17M+21.7%$325.63M$185.71M$200.57M$235.16M
$9.52M-31.8%$10.71M$11.81M$12.89M$13.95M
$9.52M-31.8%$10.71M$11.81M$12.89M$13.95M
$133.41M+177%$162.14M$33.69M$26.84M$48.15M
$9.52M-31.8%$10.71M$11.81M$12.89M$13.95M
$27.81M+12.3%$29.39M$25.75M$26.28M$24.75M
$27.81M+12.3%$29.39M$25.75M$26.28M$24.75M
$0$17.06M$17.04M
$720K+24.1%$716K$700K$599K$580K
$0$0$0$0$0
$25.48M$25.35M$25.05M
$93.72M$96.44M$99.03M
$5.6M-53.1%$7.25M$8.84M$10.38M$11.94M
$6.41M+5.9%$6.3M$6.18M$6.15M$6.06M
$19.86M-5.8%$20.55M$19.3M$19.6M$21.07M
$141.93M$147.32M$152.53M
$52.81M-25.0%$51.36M$72.08M$63.47M$70.4M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Omeros's total assets?
Omeros (OMER) holds $286.2M in total assets, up 21.7% year over year.
How much cash does Omeros have?
Omeros holds $1.9M in cash and equivalents.
Can Omeros cover its short-term obligations?
Its current ratio is 3.03 — current assets exceed current liabilities.
Where does Omeros's balance sheet data come from?
Every line is extracted from Omeros's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.